Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

13 treatments under study, led by Daily Diary Surveys

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07564648Not ApplicableRecruitingPrimary

Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability

NCT07131891CompletedPrimary

The Effects of Electronic Cigarette and Traditional Cigarette

NCT02398487Not ApplicableCompletedPrimary

Personal Vaporizer vs Cigalike

Showing all 3 trials

Research Network

Common Treatments

  • Daily Diary Surveys1
  • Biospecimen Collection1
  • Cigarette Purchase Task1
  • Questionnaire Administration1
  • Cigalike With Nicotine1

Active Sponsors

  • Ohio State University Comprehensive Cancer Center1
  • National Institute on Drug Abuse (NIDA)1
  • University of Catania1
  • Atılım University1

Top Investigators

Related Conditions

  • Tobacco Use Disorder1

Activity Timeline